drugset
drugset / Trial / NCT06144255

Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI)

NCT06144255 ↗

Phase 1 Completed 6 enrolled Florian Schmitzberger
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to study the brain response using functional MRI (fMRI) before and after varying doses of insulin given through the nose. The magnetic resonance imaging uses a very strong magnet to produce images of participant's brain. It becomes a functional MRI when the study team looks at the activity within the brain (blood flow / change in metabolism).

Timeline

Start
2023-11-17
Primary completion
2024-02-22
Completion
2024-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 500 iu Intranasal
Subject Insulin Protein / enzyme biologic 1000 iu Intranasal

Indications

No indication recorded.